Hormone therapy does not affect depression severity in older women

American Journal of Geriatric Psychiatry

Volumn 13, Issue 7, 2005, Pages 616-623

  Goldstein, Karen M ^a   Harpole, Linda H ^a   Stechuchak, Karen M ^a   Coffman, Cynthia J ^a   Bosworth, Hayden B ^a   Steffens, David C ^a   Bastian, Lori A ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEALTH EDUCATION; HORMONAL THERAPY; HUMAN; MOOD CHANGE; RANDOMIZED CONTROLLED TRIAL; CROSS-SECTIONAL STUDY; DYSTHYMIA; ESTROGEN THERAPY; MAJOR DEPRESSION; METHODOLOGY; POSTMENOPAUSE; PSYCHOLOGICAL ASPECT;

AGED; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DYSTHYMIC DISORDER; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS;

EID: 32944465782     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-200507000-00010     Document Type: Article

References (38)

1. Lebowitz BD, Pearson JL, Schneider LS, et al: Diagnosis and Treatment of Depression in Late Life: Consensus Statement Update. JAMA 1997; 278:1186-1190
2. Nicol-Smith L: Causality, menopause, and depression: a critical review of the literature. BMJ 1996; 313:1229-1232
3. Stoppe G, Dören M: Critical appraisal of effects of estrogen replacement therapy on symptoms of depressed mood. Archives of Women's Mental Health 2002; 5:39-47
4. McEwen BS: Invited Review: Estrogen's effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol 2001; 91:2785-2801
5. Stahl SM: Basic Psychopharmacology of antidepressants, part 2: estrogen as an adjunct to antidepressant treatment. J Clin Psychiatry 1998; 59(suppl 4):15-24
6. Birkhäuser M: Depression, menopause, and estrogens: is there a correlation? Maturitas 2002; 41(suppl 1):S3-S8
7. Meyers BS, Moline ML: The role of estrogen in late-life depression: opportunities and barriers to research. Psychopharm Bull 1997; 33:289-291
8. Grady D, Yaffe K, Kristof M, et al: Effect of postmenopausal hormone therapy on cognitive function: The Heart and Estrogen/Progestin Replacement Study. Am J Med 2002; 113:543-548
9. Hlatky MA, Boothroyd D, Vittinghof E, et al: Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy. JAMA 2002; 287:591-597
10. Hays J, Ockene JK, Brunner RL, et al: Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003; 348:1839-1854
11. Whooley MA, Grady D, Cauley JA, et al: Postmenopausal estrogen therapy and depressive symptoms in older women. J Gen Intern Med 2000; 15:535-541
12. Steffens DC, Norton MC, Plassman BL, et al: Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women. J Am Geriatr Soc 1999; 47:1171-1175
13. Palinkas LA, Barrett-Connor E: Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 1992; 80:30-36
14. Miller KJ, Conney JC, Rasgon NL, et al: Mood symptoms and cognitive performance in women estrogen users and non-users and men. J Am Geriatr Soc 2002; 50:1826-1830
15. Unützer J, Katon W, Williams JW Jr, et al: Improving primary care for depression in late life: the design of a multicenter, randomized trial. Med Care 2001; 39:785-799
16. Unützer J, Katon W, Callahan CM, et al: Collaborative care management of late-life depression in the primary-care setting: a randomized, controlled trial. JAMA 2002; 288:2836-2845
17. Unützer J, Katon W, Callahan CM, et al: Depression treatment in a sample of 1,801 depressed older adults in primary care. J Am GeriatrSoc 2003; 51:505-514
18. Spitzer RL, Williams JB, Kroenke K, et al: Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 Study. JAMA 1994; 272:1749-1756
19. First MB, Spitzer RL, Gibbon M, et al: Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). Washington, DC, American Psychiatric Press Inc; 1996
20. Williams JB, Gibbon M, First MB, et al: The Structured Clinical Interview for DSM-III-R (SCID): multisite test-retest reliability. Arch Gen Psychiatry 1992; 49:630-636
21. Derogatis LR, Lipman RS, Covi L: SCL-90: an outpatient psychiatric rating scale. Psychopharmacol Bull 1973; 9:13-28
22. Katon W, Robinson P, Von Korff M, et al: A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 1996; 53:924-932
23. Katon W, Von Korff M, Lin E, et al: Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA 1995; 273:1026-1031
24. Katon W, Von Korff M, Lin E, et al: Stepped collaborative care for primary-care patients with persistent symptoms of depression. Arch Gen Psychiatry 1999; 56:1109-1115
25. Derogatis LR, Rickels K, Uhlenhuth EH, et al: The Hopkins Symptom Checklist: a measure of primary symptom dimensions, in Psychological Measurements in Psychopharmacology: Problems in Pharmacopsychiatry Edited by Pichot P. Basel, Switzerland, Kargerman, 1974, pp 79-111
26. Little RJA, Rubin DB: Statistical Analysis with Missing Data. New York, Wiley, 1987
27. Matthews KA, Kuller LH, Wing RR, et al: Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 1996; 143:971-978
28. Bastian LA, Couchman GM, Rimer BK, et al: Perceptions of menopausal stage and patterns of hormone replacement therapy use. J Women's Health 1997; 6:467-475
29. Weng HH, McBride CM, Bosworth HB, et al: Racial differences in physician recommendation of hormone replacement therapy. Prev Med 2001; 33:668-673
30. Zweifel JE, O'Brien WH: A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinol 1997; 22:189-212
31. Klaiber EL, Broverman DM, Vogel W, et al: Relationships of serum estradiol levels, menopausal duration, and mood during hormonal replacement therapy. Psychoneuroendocrinol 1997; 22: 549-558
32. Hulley S, Grady D, Bush T, et al: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280:605-613
33. Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized, Controlled Trial. JAMA 2002; 288:321-333
34. Grodstein F, Manson J, Colditz G, et al: A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000; 133:933-941
35. Tam L, Parry B: Does estrogen enhance the antidepressant effects of fluoxetine? J Affect Disord 2003; 77:87-92
36. Schneider LS, Small GW, Clary CM: Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. Am J Geriatr Psychiatry 2001; 9:393-399
37. Rubin DB: Multiple Imputation for Nonresponse in Surveys. New York, Wiley, 1987
38. Li KH, Raghunathan TE, Rubin DB: Large-sample significance levels from multiply-imputed data using moment-based statistics and F reference distribution. J Am Stat Assoc 1991; 86:1065-1073